Drug recall · August 5, 2026
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution recall
Why: Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873. NDC 42571-147-26.
- Lots / codes
Lot # DLHU0031, Exp Date: 06/30/2027.
- Quantity
- N/A
- Company
- Micro Labs USA Inc, Somerset, NJ
- Distribution
- Nationwide in the USA.
- Initiated
- July 22, 2026 · Voluntary: Firm initiated
- Classified
- July 24, 2026
- Reported
- August 5, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dorzolamide / timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.